Gossamer Bio Long Term Deferred Assets (Quarterly) Insights

Gossamer Bio, Inc. (GOSS)

2.60 +0.08 (+3.17%) USD | NASDAQ | Jan 20, 16:00

2.55 -0.05 (-1.92%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for GOSS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
XOMA Royalty Corp.	--
Rezolute, Inc.	--
Axsome Therapeutics, Inc.	--
Crinetics Pharmaceuticals, Inc.	--